Wall Street Journal (May 15)
2020/ 05/ 17 by jd in Global News
“It is always hard anticipating successful drugs, but those wagering on coronavirus treatments face unique challenges. Some of the most innovative and promising approaches are wholly unproven. Companies are competing with foreign nations and not-for-profit organizations determined to achieve their own breakthroughs. Successful drugs or vaccines may run into pricing, manufacturing and distribution difficulties.” Issues like these explain why “big investors aren’t betting it all on a coronavirus cure.”
Tags: Breakthroughs, Challenges, Coronavirus, Distribution, Drugs, Innovative, Manufacturing, NPOs, Pricing, Unproven, Vaccines
